We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Emergent BioSolutions to Acquire Healthcare Protective Products Division of Bracco Diagnostics Inc.

News   Apr 26, 2013

 
Emergent BioSolutions to Acquire Healthcare Protective Products Division of Bracco Diagnostics Inc.
 
 
Advertisement
 

RELATED ARTICLES

Urine-Based Liquid Biopsy Test Outperforms Urine Cytology in Detecting Bladder Cancer

News

Analysis of DNA copy number variants in the cells exfoliated in urine showed better sensitivity and similar specificity in detecting urothelial carcinoma compared with urine cytology.

READ MORE

Risk of Deadly Skin Cancer May Be Gauged by Accumulated DNA Damage

News

Risk for melanoma, the most deadly skin cancer, can be estimated long before detection of any suspicious moles, according to a UC San Francisco scientist who led a new study to detect DNA mutations in individual skin cells.

READ MORE

Diagnosing COVID-19 in Just 30 Minutes

News

A joint research team comprised of Professor Jeong Wook Lee and Ph.D. candidate Chang Ha Woo and Professor Gyoo Yeol Jung and Dr. Sungho Jang have together developed a SENSR (SENsitive Splint-based one-pot isothermal RNA detection) technology that allows anyone to easily and quickly diagnose COVID-19 based on the RNA sequence of the virus.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE